Symposium on renal lithiasis. Medical aspects of renal calculous disease. Treatment and prophylaxis.
D000141:Acidosis, Renal Tubular / Q000150:complications; D000493:Allopurinol / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D003555:Cystinuria / Q000150:complications; D004032:Diet; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006961:Hyperparathyroidism / Q000150:complications; D007669:Kidney Calculi / Q000517:prevention & control / Q000628:therapy; D008277:Magnesium Oxide / Q000627:therapeutic use; D008297:Male; D007691:Medullary Sponge Kidney / Q000150:complications; D008661:Metabolism, Inborn Errors / Q000150:complications; D008751:Methylene Blue / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010710:Phosphates / Q000009:adverse effects / Q000627:therapeutic use; D014545:Urinary Calculi / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D014969:Xanthine Oxidase / Q000172:deficiency
D000900:Anti-Bacterial Agents; D010710:Phosphates; D006852:Hydrochlorothiazide; D008277:Magnesium Oxide; D000493:Allopurinol; D014969:Xanthine Oxidase; D010396:Penicillamine; D008751:Methylene Blue